Buscar
Mostrando ítems 1-10 de 40
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational Study
(American College of Physicians, 2022)
Background: The transition to dolutegravir-containing antiretroviral therapy (ART) in low- and middle-income countries (LMICs) was complicated by an initial safety signal in May 2018 suggesting that exposure to dolutegravir ...
Dolutegravir monotherapy as a simplified strategy in virologically suppressed HIV-1-infected patients
(Oxford University Press, 2019)
Dolutegravir monotherapy as a simplified strategy in virologically suppressed HIV-1-infected patients
(Oxford University Press, 2016)
Avaliação dos efeitos cardiometabólicos do inibidor de integrase Dolutegravir
(Universidade Federal de Minas GeraisBrasilICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICAPrograma de Pós-Graduação em Ciências Biológicas - Fisiologia e FarmacologiaUFMG, 2020-03-24)
Increasing evidence demonstrates the increased rates of cardiovascular disease among people living with HIV / AIDS. Both HIV-1 infection and antiretroviral therapy are implicated in the development of dyslipidemia, increased ...
Alteração no índice de massa corpórea: um estudo de coorte em indivíduos em uso de dolutegravir atendidos em um serviço especializado de Belo Horizonte.
(Universidade Federal de Minas GeraisBrasilFARMACIA - FACULDADE DE FARMACIAPrograma de Pós-Graduação em Medicamentos e Assistencia FarmaceuticaUFMG, 2020-10-09)
Objective: To evaluate changes in BMI variation among PLHIV after the beginning or modification of ART to a therapeutic regimen with DTG. Methods: Retrospective and prospective cohort of individuals registered in a reference ...
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
(2013)
Background: Dolutegravir (GSK1349572), a once-daily HIV integrase inhibitor, has shown potent antiviral response and a favourable safety profile. We evaluated safety, efficacy, and emergent resistance in antiretroviral-e ...
Avaliação de exames laboratoriais de glicose, ureia, creatinina e marcadores de função hepática em pessoas iniciando terapia antirretroviral com dolutegravir ou efavirenz: estudo de coorte em Belo Horizonte-MG.
(Universidade Federal de Minas GeraisBrasilFARMACIA - FACULDADE DE FARMACIAPrograma de Pós-Graduação em Medicamentos e Assistencia FarmaceuticaUFMG, 2022-06-09)
The Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome is
considered a global health problem. Antiretroviral therapy has significantly improved
the quality of life for people living with HIV. The use of the ...